查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1587919

核黃素市場：依形式、依來源、依應用、按地區

Riboflavin Market, By Form, By Source, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

核黃素市場預計到2024年將達到4.615億美元，到2031年將達到7.26億美元，2024年至2031年的複合年成長率為6.7%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 4.615 億美元
實際資料 2019-2023 預測期 2024-2031
預測期間（2024-2031）複合年成長率： 6.70% 2031 年金額預測 7.26 億美元
圖：2024 年按地區分類的核黃素市場佔有率(%)
核黃素市場-IMG1

核黃素又稱維生素B2，是人體生長發育所需的必需營養素。它作為黃素單核苷酸和黃素腺嘌呤二核苷酸的前體，在各種代謝過程中發揮重要作用。核黃素是一種水溶性維生素，必須從飲食中攝取。核黃素天然存在於多種食品中，包括牛奶、雞蛋、肉類、綠葉類、蘑菇和豆類。缺乏核黃素會導致健康問題，例如嘴角乾裂、口腔內發炎、喉嚨痛、皮膚搔癢和脂漏性皮膚炎。由於健康意識的提高和膳食食品需求的增加，全球核黃素在不久的將來可能會出現成長。

市場動態

全球核黃素市場的成長是由消費者對營養食品偏好的增加、健康意識的提高、核黃素缺乏病例的增加以及食品和飲料行業的擴張等因素所推動的。然而，從食品或合成生產中天然提取核黃素的高成本可能會阻礙市場成長。核黃素作為藥品、化妝品和飼料添加劑的新用途可能會開闢新的市場擴張途徑。然而，由於許多日常食品都含有核黃素，市場面臨一定的限制因素。嚴格的食品補充劑監管標準可能會阻礙市場成長。核黃素很難透過非肉類飲食獲得，因此擴大採用素食和素食飲食可能代表著一個成長機會。導致配方改進的產品創新帶來了另一個成長前景。

本研究的主要特點

該報告詳細分析了全球核黃素市場，並提供了以 2023 年為基準年的預測期（2024-2031）的市場規模（百萬美元）和年複合成長率（CAGR%）。

它還闡明了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

它根據公司亮點、產品系列、主要亮點、業績和策略等參數，介紹了全球核黃素市場中主要企業的概況。

本研究涵蓋的主要企業有BASF股份公司、皇家帝斯曼公司、上海創諾藥業Group Limited、信發藥業股份有限公司、湖北廣濟藥局股份有限公司、NBGroup Limited、Hegno、聯想工業有限公司、河北聖雪大成藥業有限公司、Duchefa Biochemie、Harman Finichem有限公司等

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

核黃素全球市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員可以透過用於分析全球核黃素市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • PEST分析
    • 波特的五力分析
    • 市場機會
    • 監管場景
    • 主要進展
    • 產業動態

第4章全球核黃素市場－冠狀病毒 (COVID-19) 大流行的影響

  • 影響全球核黃素市場的因素 – COVID-19
  • 影響分析

第5章全球核黃素市場，依形式分類，2019-2031（百萬美元）

  • 粉末
  • 液體

第6章 2019-2031 年全球核黃素市場（依來源）（百萬美元）

  • 植物
  • 動物

第7章 全球核黃素市場，依應用分類，2019-2031（百萬美元）

  • 食品/飲料
  • 食品補充品
  • 製藥
  • 動物飼料
  • 個人護理
  • 其他

第8章全球核黃素市場，按地區，2019-2031（百萬美元）

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 熱圖分析
  • 市場佔有率分析（3x3矩陣）
  • 公司簡介
    • BASF SE
    • Koninklijke DSM NV
    • Shanghai Acebright Pharmaceuticals Group Co. Ltd.
    • Xinfa Pharmaceutical Co. Ltd
    • Hubei Guangji Pharmaceutical Co. Ltd
    • NB Group Co. Ltd
    • Hegno
    • Legend Industries
    • Hebei Shengxue dacheng Pharmaceutical Co. Ltd
    • Duchefa Biochemie
    • Harman Finichem Ltd

第10章分析師建議

  • 命運之輪
  • 分析師觀點
  • Coherent Opportunity Map

第11章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI5140

Riboflavin market is estimated to be valued at USD 461.5 Mn in 2024 and is expected to reach USD 726.0 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 461.5 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 6.70% 2031 Value Projection: US$ 726.0 Mn
Figure. Riboflavin Market Share (%), By Region 2024
Riboflavin Market - IMG1

Riboflavin, also known as vitamin B2, is an essential nutrient required by the human body for growth and development. It plays a vital role in various metabolic processes through its involvement as a precursor for flavin mononucleotide and flavin adenine dinucleotide. As a water-soluble vitamin, riboflavin needs to be supplemented through diet. It is naturally present in a variety of foods including milk, eggs, meat, leafy green vegetables, mushrooms, and legumes. Deficiency of riboflavin can lead to health issues like cracks at the corners of the mouth, inflammation of the mouth, sore throat, itchy skin, and seborrheic dermatitis. Due to growing health awareness and increasing demand for nutritional supplements, global riboflavin can witness growth in the near future.

Market Dynamics-

Global riboflavin market growth is driven by factors such as increasing consumer preference for nutritional supplements, growing health consciousness, rising cases of riboflavin deficiencies, and expanding food & beverage industry. However, high costs associated with natural extraction of riboflavin from foods and synthetic production can hamper the market growth. Novel applications of riboflavin as an additive in pharmaceuticals, cosmetics and animal feed can present new avenues for market expansion. However, the market faces certain restraints due to presence of riboflavin in many routine foods. Strict regulatory norms governing dietary supplements can hamper the market growth. Increasing adoption of vegan and vegetarian diets as riboflavin intake can be challenging through a non-meat diet can offer growth opportunities. Product innovation leading to enhanced formulations presents another favorable growth prospect.

Key Features of the Study-

This report provides in-depth analysis of the global riboflavin market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global riboflavin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include BASF SE, Koninklijke DSM NV, Shanghai Acebright Pharmaceuticals Group Co. Ltd., Xinfa Pharmaceutical Co. Ltd, Hubei Guangji Pharmaceutical Co. Ltd, NB Group Co. Ltd, Hegno, Legend Industries, Hebei Shengxue dacheng Pharmaceutical Co. Ltd, Duchefa Biochemie, and Harman Finichem Ltd

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global riboflavin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global riboflavin market

Market Segmentation

  • Form Insights (Revenue, USD, 2019 - 2031)
    • Powder
    • Liquid
  • Source Insights (Revenue, USD, 2019 - 2031)
    • Plant
    • Animal
  • Application Insights (Revenue, USD, 2019 - 2031)
    • Food and Beverages
    • Dietary Supplements
    • Pharmaceutical
    • Animal Feed
    • Personal Care
    • Others
  • Regional Insights (Revenue, USD, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • BASF SE
    • Koninklijke DSM NV
    • Shanghai Acebright Pharmaceuticals Group Co. Ltd.
    • Xinfa Pharmaceutical Co. Ltd
    • Hubei Guangji Pharmaceutical Co. Ltd
    • NB Group Co. Ltd
    • Hegno
    • Legend Industries
    • Hebei Shengxue dacheng Pharmaceutical Co. Ltd
    • Duchefa Biochemie
    • Harman Finichem Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Form
    • Market Snippet, By Source
    • Market Snippet, By Application
    • Market Snippet, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Riboflavin Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overview
  • Factors Affecting the Global Riboflavin Market - COVID-19
  • Impact Analysis

5. Global Riboflavin Market, By Form, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Powder
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
  • Liquid
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
    • Segment Trends

6. Global Riboflavin Market, By Source, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Plant
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
  • Animal
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends

7. Global Riboflavin Market, By Application, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Food and Beverages
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
  • Dietary Supplements
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
  • Pharmaceutical
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
  • Animal Feed
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
  • Personal Care
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
  • Others
    • Market Share Analysis, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends

8. Global Riboflavin Market, By Region, 2019-2031, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024, 2027, and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020 - 2031
  • North America
    • Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Country, 2019- 2031, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Market Size and Forecast, By Form, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Source, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Application, 2019- 2031, (USD Mn)
    • Market Size and Forecast, By Country/Region, 2019- 2031, (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • BASF SE
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Koninklijke DSM NV
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Shanghai Acebright Pharmaceuticals Group Co. Ltd.
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Xinfa Pharmaceutical Co. Ltd
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Hubei Guangji Pharmaceutical Co. Ltd
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • NB Group Co. Ltd
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Hegno
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Legend Industries
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Hebei Shengxue dacheng Pharmaceutical Co. Ltd
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Duchefa Biochemie
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Harman Finichem Ltd
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact